166 related articles for article (PubMed ID: 26676859)
1. DC BeadM1™: towards an optimal transcatheter hepatic tumour therapy.
Lewis AL; Dreher MR; O'Byrne V; Grey D; Caine M; Dunn A; Tang Y; Hall B; Fowers KD; Johnson CG; Sharma KV; Wood BJ
J Mater Sci Mater Med; 2016 Jan; 27(1):13. PubMed ID: 26676859
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel intrinsically radiopaque Drug-eluting Bead for image-guided therapy: DC Bead LUMI™.
Ashrafi K; Tang Y; Britton H; Domenge O; Blino D; Bushby AJ; Shuturminska K; den Hartog M; Radaelli A; Negussie AH; Mikhail AS; Woods DL; Krishnasamy V; Levy EB; Wood BJ; Willis SL; Dreher MR; Lewis AL
J Control Release; 2017 Mar; 250():36-47. PubMed ID: 28188808
[TBL] [Abstract][Full Text] [Related]
3. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization.
Lewis AL; Gonzalez MV; Lloyd AW; Hall B; Tang Y; Willis SL; Leppard SW; Wolfenden LC; Palmer RR; Stratford PW
J Vasc Interv Radiol; 2006 Feb; 17(2 Pt 1):335-42. PubMed ID: 16517780
[TBL] [Abstract][Full Text] [Related]
4. Preparation of Radiopaque Drug-Eluting Beads for Transcatheter Chemoembolization.
Johnson CG; Tang Y; Beck A; Dreher MR; Woods DL; Negussie AH; Donahue D; Levy EB; Willis SL; Lewis AL; Wood BJ; Sharma KV
J Vasc Interv Radiol; 2016 Jan; 27(1):117-126.e3. PubMed ID: 26549370
[TBL] [Abstract][Full Text] [Related]
5. Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer.
Forster RE; Small SA; Tang Y; Heaysman CL; Lloyd AW; Macfarlane W; Phillips GJ; Antonijevic MD; Lewis AL
J Mater Sci Mater Med; 2010 Sep; 21(9):2683-90. PubMed ID: 20563626
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbit.
Namur J; Pascale F; Maeda N; Sterba M; Ghegediban SH; Verret V; Paci A; Seck A; Osuga K; Wassef M; Reb P; Laurent A
J Vasc Interv Radiol; 2015 Jul; 26(7):1067-1075.e3. PubMed ID: 25952641
[TBL] [Abstract][Full Text] [Related]
7. Stability of irinotecan-loaded drug eluting beads (DC Bead) used for transarterial chemoembolization.
Kaiser J; Thiesen J; Krämer I
J Oncol Pharm Pract; 2010 Mar; 16(1):53-61. PubMed ID: 19617306
[TBL] [Abstract][Full Text] [Related]
8. Handling and performance characteristics of a new small caliber radiopaque embolic microsphere.
Lewis AL; Caine M; Garcia P; Ashrafi K; Tang Y; Hinchcliffe L; Guo W; Bascal Z; Kilpatrick H; Willis SL
J Biomed Mater Res B Appl Biomater; 2020 Oct; 108(7):2878-2888. PubMed ID: 32578348
[TBL] [Abstract][Full Text] [Related]
9. Loading, release and stability of epirubicin-loaded drug-eluting beads.
Spindeldreier KC; Thiesen J; Krämer I
J Oncol Pharm Pract; 2016 Aug; 22(4):591-8. PubMed ID: 26160072
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of ion exchange processes in drug-eluting embolization beads by use of an improved flow-through elution method.
Swaine T; Tang Y; Garcia P; John J; Waters LJ; Lewis AL
Eur J Pharm Sci; 2016 Oct; 93():351-9. PubMed ID: 27523788
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan.
Jordan O; Denys A; De Baere T; Boulens N; Doelker E
J Vasc Interv Radiol; 2010 Jul; 21(7):1084-90. PubMed ID: 20610183
[TBL] [Abstract][Full Text] [Related]
12. Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model.
Namur J; Wassef M; Millot JM; Lewis AL; Manfait M; Laurent A
J Vasc Interv Radiol; 2010 Feb; 21(2):259-67. PubMed ID: 20123210
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Characterization of a Novel Type of Radiopaque Doxorubicin-Loaded Microsphere.
Pan F; Schneider D; Ryschich E; Qian B; Vollherbst DF; Möhlenbruch MA; Jugold M; Eichwald V; Stenzel P; Pereira PL; Richter GM; Kauczor HU; Sommer CM; Do TD
Cardiovasc Intervent Radiol; 2020 Apr; 43(4):636-647. PubMed ID: 31965224
[TBL] [Abstract][Full Text] [Related]
14. Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine.
Dreher MR; Sharma KV; Woods DL; Reddy G; Tang Y; Pritchard WF; Chiesa OA; Karanian JW; Esparza JA; Donahue D; Levy EB; Willis SL; Lewis AL; Wood BJ
J Vasc Interv Radiol; 2012 Feb; 23(2):257-64.e4. PubMed ID: 22178039
[TBL] [Abstract][Full Text] [Related]
15. Development of a combination drug-eluting bead: towards enhanced efficacy for locoregional tumour therapies.
Forster RE; Tang Y; Bowyer C; Lloyd AW; Macfarlane W; Phillips GJ; Lewis AL
Anticancer Drugs; 2012 Apr; 23(4):355-69. PubMed ID: 22241169
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin and irinotecan drug-eluting beads for treatment of glioma: a pilot study in a rat model.
Baltes S; Freund I; Lewis AL; Nolte I; Brinker T
J Mater Sci Mater Med; 2010 Apr; 21(4):1393-402. PubMed ID: 20162337
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin eluting beads-2: methods for evaluating drug elution and in-vitro:in-vivo correlation.
Gonzalez MV; Tang Y; Phillips GJ; Lloyd AW; Hall B; Stratford PW; Lewis AL
J Mater Sci Mater Med; 2008 Feb; 19(2):767-75. PubMed ID: 17653626
[TBL] [Abstract][Full Text] [Related]
18. Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media.
Sarakbi I; Krämer I
J Oncol Pharm Pract; 2016 Dec; 22(6):749-756. PubMed ID: 26428284
[TBL] [Abstract][Full Text] [Related]
19. Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead.
Malagari K
Expert Rev Anticancer Ther; 2008 Oct; 8(10):1643-50. PubMed ID: 18925855
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: a stability assessment.
Hecq JD; Lewis AL; Vanbeckbergen D; Athanosopoulos A; Galanti L; Jamart J; Czuczman P; Chung T
J Oncol Pharm Pract; 2013 Mar; 19(1):65-74. PubMed ID: 22801955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
